Genetic influences on cognitive decline in Parkinson's disease.

Movement Disorders : Official Journal of the Movement Disorder Society
James F MorleyAndrew Siderowf

Abstract

The role of genetic factors in cognitive decline associated with Parkinson's disease (PD) is unclear. We examined whether variations in apolipoprotein E (APOE), microtubule-associated protein tau (MAPT), or catechol-O-methytransferase (COMT) genotypes are associated with cognitive decline in PD. We performed a prospective cohort study of 212 patients with a clinical diagnosis of PD. The primary outcome was change in Mattis Dementia Rating Scale version 2 score. Linear mixed-effects models and survival analysis were used to test for associations between genotypes and change in cognitive function over time. The ε4 allele of APOE was associated with more rapid decline (loss of 2.9; 95% confidence interval [CI]: 1.7-4.1) of more points per year; P < 0.001) in total score and an increased risk of a ≥ 10 point drop during the follow-up period (hazard ratio, 2.8; 95% CI: 1.4-5.4; P = 0.003). MAPT haplotype and COMT genotype were associated with measures of memory and attention, respectively, over the entire follow-up period, but not with the overall rate of cognitive decline. These results confirm and extend previously described genetic associations with cognitive decline in PD and imply that individual genes may exert effects on spec...Continue Reading

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Mar 21, 1998·JAMA : the Journal of the American Medical Association·M X TangR Mayeux
Jan 5, 2000·Journal of Geriatric Psychiatry and Neurology·G G BrownC Shults
Mar 29, 2001·Neurology·D AarslandP Kragh-Sørensen
Dec 15, 2004·Archives of Neurology·Dag AarslandPer Kragh-Sørensen
Jul 26, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Dag AarslandCarol Brayne
Aug 24, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Nathan PankratzWilliam C Nichols
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Feb 16, 2006·Archives of Neurology·Xuemei HuangCharles Poole
Jan 6, 2007·Neuroscience Letters·Spiridon PapapetropoulosDeborah C Mash
May 31, 2007·Brain : a Journal of Neurology·C H Williams-GrayR A Barker
Aug 9, 2007·Annals of Neurology·An GorisStephen J Sawcer
Jan 8, 2008·Brain : a Journal of Neurology·Caroline H Williams-GrayAdrian M Owen
Feb 26, 2008·Nature Neuroscience·Gilbert GallardoThomas C Südhof
Mar 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Mariese A HelyJohn G L Morris
Jun 12, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Gisela LlebariaMercè Martínez-Corral
Oct 22, 2008·Neuroscience Letters·Mario EzquerraEduardo Tolosa
Nov 8, 2008·Current Opinion in Neurology·Dag AarslandMartin W Kurz
Nov 21, 2008·Neurology·D AarslandUNKNOWN Norwegian ParkWest Study Group
Mar 25, 2009·Journal of Neurology·Caroline H Williams-GrayRoger A Barker
Mar 27, 2009·Journal of Geriatric Psychiatry and Neurology·Martin Wilhelm KurzGuido Alves
Apr 15, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A C LudolphUNKNOWN Reisensburg Working Group for Tauopathies With Parkinsonism
Oct 2, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Yaroslau ComptaEduardo Tolosa
Oct 9, 2009·Brain : a Journal of Neurology·Caroline H Williams-GrayRoger A Barker
Feb 27, 2010·Annals of Neurology·John C MorrisMark A Mintun
Apr 30, 2010·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Otto PedrazaRobert J Ivnik
Sep 30, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Jeroen HooglandBart Post
Mar 16, 2011·Archives of Neurology·Núria Setó-SalviaJaime Kulisevsky
Apr 27, 2011·Annals of Neurology·Alice S Chen-PlotkinJohn Q Trojanowski

❮ Previous
Next ❯

Citations

Feb 15, 2013·JAMA Neurology·Debby TsuangCyrus P Zabetian
Aug 1, 2013·Nature Reviews. Neuroscience·David J IrwinJohn Q Trojanowski
Feb 26, 2014·Alzheimer's Research & Therapy·Mario MasellisSerge Gauthier
Aug 1, 2014·Brain : a Journal of Neurology·Cristina NombelaRoger A Barker
Sep 13, 2015·Neurology·Kara PigottDaniel Weintraub
May 11, 2015·Journal of Neurology·Emma R L C VardyAlison J Yarnall
May 23, 2015·British Medical Bulletin·Stephen Mullin, Anthony Schapira
Jan 23, 2015·Frontiers in Endocrinology·Victor Jacobus GeraedtsCaroline Sievers
Nov 12, 2014·Frontiers in Neurology·Fabiola De MarchiCristoforo Comi
Dec 3, 2014·Nature Reviews. Neurology·Dilan Athauda, Thomas Foltynie
Apr 23, 2016·Expert Review of Neurotherapeutics·Hee Jin Kim, Beomseok Jeon
Jun 1, 2016·Frontiers in Psychiatry·Lucy M Collins, Caroline H Williams-Gray
Aug 19, 2014·Neurobiology of Disease·David A HottmanLing Li
Mar 4, 2017·Nature Reviews. Neurology·Dag AarslandClive Ballard
Apr 4, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Stéphane LehericyUNKNOWN International Parkinson and Movement Disorder Society (IPMDS)-Neuroimaging Study Group
Apr 8, 2017·Journal of Parkinson's Disease·Laura BrennanDaniel Weintraub
May 19, 2017·PloS One·Chelsea Caspell-GarciaUNKNOWN Parkinson’s Progression Markers Initiative (PPMI)
Feb 22, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E S Fagan, L Pihlstrøm
Oct 27, 2017·Chinese Medical Journal·Lin LiMao-Ting Yuan
Mar 18, 2015·International Journal of Geriatric Psychiatry·John V HindleLinda Clare
Sep 27, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·K A SenkevichS N Pchelina
Mar 8, 2018·BMC Medicine·Kurt A Jellinger, Amos D Korczyn
Dec 15, 2012·Expert Review of Neurotherapeutics·Kurt A Jellinger
Apr 24, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Brit MollenhauerDavid Brooks
Apr 24, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Glenda M HallidayCharles H Adler
Feb 19, 2016·Journal of Parkinson's Disease·Matthew J BarrettBradford B Worrall
May 20, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Manuel Delgado-AlvaradoMaría C Rodriguez-Oroz
Apr 12, 2016·Journal of Parkinson's Disease·Jori E FleisherJudy A Shea
Apr 12, 2016·Journal of Parkinson's Disease·Kimberly C PaulBeate Ritz
Nov 24, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Thomas F TropeaAlice S Chen-Plotkin
Aug 14, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·V V Kozak
Dec 24, 2019·Journal of Parkinson's Disease·Aaron Ben-JosephAlastair J Noyce
Aug 9, 2020·Annals of Clinical and Translational Neurology·Angela B DeutschlanderOwen A Ross
Oct 1, 2016·Dementia & Neuropsychologia·Carlos Henrique Ferreira CamargoMarcelo Rezende Young-Blood
Dec 12, 2017·Brain : a Journal of Neurology·Nicola J RayMichel J Grothe
Apr 10, 2019·Journal of Neural Transmission·Saul Martinez-Horta, Jaime Kulisevsky
Feb 7, 2020·Science Translational Medicine·Albert A DavisDavid M Holtzman
Aug 1, 2019·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·Qian WangZhuoyou Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Researcher Network:CZI Neurodegeneration Challenge

The Neurodegeneration Challenge Network aims to provide funding for and to bring together researchers studying neurodegenerative diseases. Find the latest research from the NDCN grantees here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Dag AarslandFiona Matthews
Movement Disorders : Official Journal of the Movement Disorder Society
Carmen C JanvinKenneth Hugdahl
Movement Disorders : Official Journal of the Movement Disorder Society
K Marder
© 2022 Meta ULC. All rights reserved